LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER

Clinical trials for LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to improve stomach cancer surgery outcomes

Disease control Not yet recruiting

This study tests whether adding the drug adebrelimab to standard chemotherapy (S-1 and oxaliplatin) before and after surgery helps people with stomach or gastroesophageal junction cancer live longer without the cancer returning. About 874 adults aged 18-74 with locally advanced, …

Matched conditions: LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER

Phase: PHASE3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Disease control

Last updated May 11, 2026 20:50 UTC

LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER

Get alerted when new LOCALLY ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER trials appear

New drug combo aims to improve stomach cancer surgery outcomes